Prades R - Search Results

1

Rational design of a selective covalent modifier of G protein βγ subunits.

Dessal AL, Prades R, Giralt E, Smrcka AV. Dessal AL, et al. Among authors: prades r. Mol Pharmacol. 2011 Jan;79(1):24-33. doi: 10.1124/mol.110.068155. Epub 2010 Sep 29. Mol Pharmacol. 2011. PMID: 20881007 Free PMC article.

2

Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.

Tarragó T, Kichik N, Claasen B, Prades R, Teixidó M, Giralt E. Tarragó T, et al. Among authors: prades r. Bioorg Med Chem. 2008 Aug 1;16(15):7516-24. doi: 10.1016/j.bmc.2008.04.067. Epub 2008 Apr 29. Bioorg Med Chem. 2008. PMID: 18650094

3

A novel family of diketopiperazines as a tool for the study of transport across the blood-brain barrier (BBB) and their potential use as BBB-shuttles.

Teixidó M, Zurita E, Prades R, Tarrago T, Giralt E. Teixidó M, et al. Among authors: prades r. Adv Exp Med Biol. 2009;611:227-8. doi: 10.1007/978-0-387-73657-0_105. Adv Exp Med Biol. 2009. PMID: 19400172 No abstract available.

4

N-methyl phenylalanine-rich peptides as highly versatile blood-brain barrier shuttles.

Malakoutikhah M, Prades R, Teixidó M, Giralt E. Malakoutikhah M, et al. Among authors: prades r. J Med Chem. 2010 Mar 25;53(6):2354-63. doi: 10.1021/jm901654x. J Med Chem. 2010. PMID: 20170117

5

Dual system for the central nervous system targeting and blood-brain barrier transport of a selective prolyl oligopeptidase inhibitor.

Teixidó M, Zurita E, Mendieta L, Oller-Salvia B, Prades R, Tarragó T, Giralt E. Teixidó M, et al. Among authors: prades r. Biopolymers. 2013 Nov;100(6):662-74. doi: 10.1002/bip.22275. Biopolymers. 2013. PMID: 23893478

6

Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia.

López A, Mendieta L, Prades R, Royo S, Tarragó T, Giralt E. López A, et al. Among authors: prades r. Future Med Chem. 2013 Sep;5(13):1509-23. doi: 10.4155/fmc.13.135. Future Med Chem. 2013. PMID: 24024944 Review.

7

The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.

Prades R, Munarriz-Cuezva E, Urigüen L, Gil-Pisa I, Gómez L, Mendieta L, Royo S, Giralt E, Tarragó T, Meana JJ. Prades R, et al. Eur Neuropsychopharmacol. 2017 Feb;27(2):180-191. doi: 10.1016/j.euroneuro.2016.11.016. Epub 2016 Dec 14. Eur Neuropsychopharmacol. 2017. PMID: 27986355

8

Targeted Covalent Inhibition of Prolyl Oligopeptidase (POP): Discovery of Sulfonylfluoride Peptidomimetics.

Guardiola S, Prades R, Mendieta L, Brouwer AJ, Streefkerk J, Nevola L, Tarragó T, Liskamp RMJ, Giralt E. Guardiola S, et al. Among authors: prades r. Cell Chem Biol. 2018 Aug 16;25(8):1031-1037.e4. doi: 10.1016/j.chembiol.2018.04.013. Epub 2018 May 17. Cell Chem Biol. 2018. PMID: 29779956 Free article.

9

A MALDI-TOF-based Method for Studying the Transport of BBB Shuttles-Enhancing Sensitivity and Versatility of Cell-Based In Vitro Transport Models.

Arranz-Gibert P, Guixer B, Prades R, Ciudad S, Giralt E, Teixidó M. Arranz-Gibert P, et al. Among authors: prades r. Sci Rep. 2019 Mar 19;9(1):4875. doi: 10.1038/s41598-019-40973-0. Sci Rep. 2019. PMID: 30890722 Free PMC article.

10

Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor.

Prades R, Guerrero S, Araya E, Molina C, Salas E, Zurita E, Selva J, Egea G, López-Iglesias C, Teixidó M, Kogan MJ, Giralt E. Prades R, et al. Biomaterials. 2012 Oct;33(29):7194-205. doi: 10.1016/j.biomaterials.2012.06.063. Epub 2012 Jul 15. Biomaterials. 2012. PMID: 22795856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters